Anika Therapeutics (ANIK) Tops Q3 EPS by 3c
More News related to ANIK
- Anika Therapeutics (ANIK) Received European CE Mark for Aesthetic 'ELEVESS Light'
- Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- Anika Therapeutics (ANIK) Tops Q3 EPS by 3c
- Anika Therapeutics Reports 17% Revenue Growth in Third-Quarter 2009
More News related to Earnings
- National Bank of Greece (NBG) To Elect New Board Members on December 2
- Stocks Hit On Dubai Fallout
- Gold Hit As Dubai Woes Sends Dollar Higher
- As Economy Shows Improvement, Banks' Financing More - WSJ (JPM, C, GS, DB, CS, More)
- Dubai Debt Woes Roil Markets
Anika Therapeutics (NASDAQ: ANIK) reports Q3 EPS of $0.13, 3 cents better than the analyst estimate of $0.10. Revenue for the quarter was $10.8 million, which compares to the estimate of $10.44 million
Related Categories
EarningsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
